Intellia Therapeutics, Inc. (NTLA) ownership: ARK Investment Management LLC 13% · institutions 88% · index and ETF funds 19% (13F 2026-06-30). Insider activity, 90 days: 6 sales, 0 open-market buys. 8 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| ARK Investment Management LLC | 16875684.00 | $285.54M | 12.0% | 2026-06-30 |
| BlackRock | 15409023.00 | $260.72M | 11.0% | 2026-06-30 |
| Vanguard | 14468404.00 | $244.81M | 10.3% | 2026-06-30 |
| State Street | 9234987.00 | $156.26M | 6.6% | 2026-06-30 |
| CalSTRS | 2580588.00 | $152.52M | 1.8% | 2026-06-30 |
| D. E. Shaw | 6443323.00 | $109.02M | 4.6% | 2026-06-30 |
| Two Sigma | 5254743.00 | $88.91M | 3.7% | 2026-06-30 |
| FMR (Fidelity) | 4773034.00 | $80.76M | 3.4% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-20 | |
| Sell | null | 2026-08-20 | |
| Sell | null | 2026-07-22 | |
| Sell | null | 2026-07-02 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 |
Back to NTLA overview · NTLA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.